Fairooz F. Kabbinavar
- Oncology top 0.05%
- Pulmonary and Respiratory Medicine top 0.05%
- Molecular Biology top 0.5%
- Cancer Research top 0.2%
- Hepatology top 0.1%
- Co-authors
- Herbert I. HurwitzWilliam NovotnyLouis FehrenbacherEric HolmgrenJordan BerlinJohn D. HainsworthW. HeimThomas H. Cartwright
- Topics
- Colorectal Cancer Treatments and Studies (59 papers)Renal cell carcinoma treatment (52 papers)Cancer Treatment and Pharmacology (50 papers)
- Cited by
- OncologyHepatologyCancer Research
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Fairooz F. Kabbinavar
172 papers receiving 21.2k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Oncology 12.9k
- Pulmonary and Respiratory Medicine 8.8k
- Molecular Biology 7.8k
- Cancer Research 4.1k
- Hepatology 3.4k
Countries citing papers authored by Fairooz F. Kabbinavar
This map shows the geographic impact of Fairooz F. Kabbinavar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fairooz F. Kabbinavar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fairooz F. Kabbinavar more than expected).
Fields of papers citing papers by Fairooz F. Kabbinavar
This network shows the impact of papers produced by Fairooz F. Kabbinavar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fairooz F. Kabbinavar. The network helps show where Fairooz F. Kabbinavar may publish in the future.
Co-authorship network of co-authors of Fairooz F. Kabbinavar
This figure shows the co-authorship network connecting the top 25 collaborators of Fairooz F. Kabbinavar. A scholar is included among the top collaborators of Fairooz F. Kabbinavar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fairooz F. Kabbinavar. Fairooz F. Kabbinavar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 3 | |
| 3 | 126 | |
| 4 | 8 | |
| 5 | 5 | |
| 6 | 107 | |
| 7 | 52 | |
| 8 | PROGNOSTIC VALUE OF EARLY OBJECTIVE TUMOR RESPONSE (EOTR) TO FIRST LINE SYSTEMIC THERAPY IN METASTATIC COLORECTAL CANCER (MCRC): INDIVIDUAL PATIENT DATA (IPD) META-ANALYSIS OF RANDOMIZED TRIALS FROM THE ARCAD DATABASE | 2 |
| 9 | 25 | |
| 10 | 38 | |
| 11 | 94 | |
| 12 | 58 | |
| 13 | 151 | |
| 14 | 135 | |
| 15 | 45 | |
| 16 | 118 | |
| 17 | Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trialbreakdown → | 709 |
| 18 | 53 | |
| 19 | 25 | |
| 20 | 43 |
About Fairooz F. Kabbinavar
Fairooz F. Kabbinavar is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 175 papers that have together received 21.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (59 papers), Renal cell carcinoma treatment (52 papers) and Cancer Treatment and Pharmacology (50 papers). The work is most often cited by research in Oncology (12.9k citations), Hepatology (3.4k citations) and Cancer Research (4.1k citations). Fairooz F. Kabbinavar has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Herbert I. Hurwitz, William Novotny, Louis Fehrenbacher, Eric Holmgren, Jordan Berlin, John D. Hainsworth, W. Heim, Thomas H. Cartwright, Napoleone Ferrara and Ari David Baron. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.